Washington, Aug. 3: Drug makers from India, the biggest source of medicines to the US, may soon have to cough up 12-15 per cent more in annual facility fees as the Food and Drug Administration (FDA) has announced new rates. US laws authorise the drug and health watchdog to assess and collect user fees for certain applications and supplements for human generic drug products. The new rates are effective from October and will remain in force through September 30, 2015.
New Delhi, Aug. 3: The finance ministry today said the Rs 6.24 lakh crore indirect tax collection target was a “challenge” as the tax buoyancy would depend on the revival of the economy and the manufacturing sector,” revenue secretary Shaktikanta Das said.
New Delhi, Aug. 3: Driven by an investment-friendly government at the centre, overseas investors have pumped in $6 billion into the Indian securities market in July — taking the overall net inflows since the beginning of 2014 to more than $26 billion.
New Delhi, Aug. 3: A policy on the utilisation of surplus coal from captive mines is likely by next month. The development comes amid reports of sale of surplus coal by some private parties in the open market against norms.
New Delhi, Aug. 3: After rejecting Reliance Industries’ gas finds, the Directorate General of Hydrocarbons (DGH) has refused to recognise three gas discoveries of state-owned ONGC for not doing the prescribed conformity tests.
